1 Vielh P,Validire P,Kheirallah S. Paget' disease of the nipple without clinically and radiologically detectable breast tumor. Pathol Res Pract, 1993,189:150-155.
2 Gee JMW, Robertson JFR, Ellis IO, et al. Immunocytochemical localization of Bcl-2 protein in human breast cancers and its relationship to a series of prognostic markers and response to endocarine therapy. Int J Cancer,1994,59:619-628.
3 Berardo MD, Elledge RM, Moor CD,et al. bcl-2 and apoptosis in lymph node positive breast carcinoma. Cancer, 1998,82:1296-1302.
4 陈丽荣,张苏展,王海军,等.凋亡相关基因在乳腺癌的表达及其预后的关系.中国癌症杂志,1998, 8:160-162.
5 Bhargava V, Kell DL, van de Rijn M, et al. Bcl-2 immunoreactivity in breast carcinoma correlates with hormone receptor positivity. Am J Pathol, 1994,145:535-540.
6 Gasparini G, Barbareschi M, Doglioni C, et al. Expression of bcl-2 protein predicts efficacy of adjuvant treatments in operable node-positive breast cancer. Clin Cancer Res,1995, 1:189-198. |
